
CNXC Stock Forecast & Price Target
CNXC Analyst Ratings
Bulls say
Concentrix Corp is expected to experience significant revenue and non-GAAP EPS growth improvements in fiscal 2026 and 2027, fueled by advancements in market share and a strategic shift toward high-value solutions. The company's technology solutions segment demonstrated a strong performance, with a 61% year-over-year increase in wins, indicating a successful adaptation to client demands and market dynamics. Additionally, total revenue rose by 5% year-over-year, reflecting resilience and growth potential, particularly in the banking sector, which is projected to maintain a solid growth trajectory.
Bears say
Concentrix Corp is demonstrating a concerning trend in its financial performance, as evidenced by a decline in adjusted EBITDA margins, which fell from 15.8% year-over-year and sequentially from 14.8% to 13.9% in fiscal Q1/26. Additionally, the company reported a reduction in adjusted operating margins from 13.6% year-over-year and sequentially from 12.7% to 11.8% during the same period, alongside a decrease in gross margins from 36.1% to 34.0%. The negative outlook is further compounded by an expected year-over-year decline of 6% and a sequential decline of 11% in EPS, with challenges in key industry sectors like healthcare anticipated to persist for several quarters.
This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.
CNXC Analyst Forecast & Price Prediction
Start investing in CNXC
Order type
Buy in
Order amount
Est. shares
0 shares